NurExone Biologic Inc. (TSXV:NRX)
Canada · Delayed Price · Currency is CAD 0.6900
+0.0300 (4.55%)
At close: Feb 27, 2026
21.05% (1Y)
| Market Cap | 62.62M +45.6% |
| Revenue (ttm) | n/a |
| Net Income | -9.10M |
| EPS | -0.12 |
| Shares Out | 90.75M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 84,016 |
| Average Volume | 32,756 |
| Open | 0.6600 |
| Previous Close | 0.6600 |
| Day's Range | 0.6500 - 0.6900 |
| 52-Week Range | 0.5500 - 1.1400 |
| Beta | 0.23 |
| RSI | 57.53 |
| Earnings Date | Mar 30, 2026 |